131 related articles for article (PubMed ID: 7577341)
1. Graft versus leukemia in humans.
Butturini A; Gale RP
Cancer Treat Res; 1995; 76():299-314. PubMed ID: 7577341
[No Abstract] [Full Text] [Related]
2. Donor antigen-presenting cells regulate T-cell expansion and antitumor activity after allogeneic bone marrow transplantation.
Li JM; Waller EK
Biol Blood Marrow Transplant; 2004 Aug; 10(8):540-51. PubMed ID: 15282532
[TBL] [Abstract][Full Text] [Related]
3. Immune recovery after bone marrow and peripheral blood stem cells transplantation.
Marin GH; Mendez MC; Menna ME; Malacalza J; Bergna MI; Klein G; Italiano C; Perez M; Gil MA; Gardenal L; Mansilla E; Orlando S; Saba S; Cánepa C; Piccinelli G
Transplant Proc; 1999 Sep; 31(6):2582-4. PubMed ID: 10500728
[No Abstract] [Full Text] [Related]
4. Transplantation of CD34+ hematopoietic precursors: clinical rationale.
Berenson RJ
Transplant Proc; 1992 Dec; 24(6):3032-4. PubMed ID: 1281584
[No Abstract] [Full Text] [Related]
5. Flow cytometric analysis of lymphocyte subsets as a predictive factor for GVHD in allogeneic bone marrow transplantation.
Marin GH; Menna ME; Saba S; Klein G; Mendez MC; Bergna MI; Italiano C; Malacalza J; Perez M; Gil MA; Gardenal L; Orlando S; Mansilla E; Cánepa C; Piccinelli G
Transplant Proc; 1999 Nov; 31(7):2973-5. PubMed ID: 10578354
[No Abstract] [Full Text] [Related]
6. The status of bone marrow transplantation for leukemia.
McGlave PB
Hosp Pract (Off Ed); 1985 Nov; 20(11):97-110. PubMed ID: 2997246
[No Abstract] [Full Text] [Related]
7. Approaches to graft-versus-host disease following bone marrow transplantation in monkeys and man.
Dicke KA; Spitzer G; Peters L; Stevens EE; Hendriks W; McCredie tkb
Transplant Proc; 1978 Mar; 10(1):217-21. PubMed ID: 416529
[No Abstract] [Full Text] [Related]
8. The use of monoclonal antibodies and immune markers in the diagnosis, prognosis, and therapy of acute leukemia.
Neame PB; Soamboonsrup P; Quigley JG; Pewarchuck W
Transfus Med Rev; 1994 Jan; 8(1):59-75. PubMed ID: 8136608
[No Abstract] [Full Text] [Related]
9. Cure after allogeneic bone marrow transplantation: chemo-radiotherapy and/or graft-versus-leukemia?
Hagenbeek A; Martens AC; Schultz FW; van Bekkum DW
Bone Marrow Transplant; 1990 Jul; 6 Suppl 1():91-3. PubMed ID: 2390645
[No Abstract] [Full Text] [Related]
10. The graft-versus-leukemia (GVL) phenomenon: is GVL separable from GVHD?
Slavin S; Ackerstein A; Naparstek E; Or R; Weiss L
Bone Marrow Transplant; 1990 Sep; 6(3):155-61. PubMed ID: 2252954
[TBL] [Abstract][Full Text] [Related]
11. Cyclosporine-induced autologous graft versus host disease: assessment of cytolytic effector mechanisms and the V beta T-cell receptor repertoire.
Ruvolo P; Bright E; Kennedy MJ; Morris L; Fischer A; Vogelsang G; Jones R; Hess A
Transplant Proc; 1995 Feb; 27(1):1363-5. PubMed ID: 7878913
[No Abstract] [Full Text] [Related]
12. The role of megadose CD34+ progenitor cells in the treatment of leukemia patients without a matched donor and in tolerance induction for organ transplantation.
Reisner Y; Bachar-Lustig E; Li HW; Aversa F; Velardi A; Martelli MF
Ann N Y Acad Sci; 1999 Apr; 872():336-48; discussion 348-50. PubMed ID: 10372136
[TBL] [Abstract][Full Text] [Related]
13. Flow cytometric analysis of the graft-versus-Leukemia-effect after hematopoietic stem cell transplantation in mice.
Schmidt F; Hilger N; Oelkrug C; Svanidze E; Ruschpler P; Eichler W; Boldt A; Emmrich F; Fricke S
Cytometry A; 2015 Apr; 87(4):334-45. PubMed ID: 25717029
[TBL] [Abstract][Full Text] [Related]
14. Bone marrow transplantation.
Kennedy MS; Lui VK; Ragab AH
Am J Med Technol; 1979 Mar; 45(3):205-10. PubMed ID: 34323
[TBL] [Abstract][Full Text] [Related]
15. Effector cells of graft-versus-host disease, host resistance, and the graft-versus-leukemia effect: summary of a workshop on bone marrow transplantation.
Ringdén O; Deeg HJ; Beschorner W; Slavin S
Transplant Proc; 1987 Feb; 19(1 Pt 3):2758-61. PubMed ID: 3547953
[No Abstract] [Full Text] [Related]
16. Engraftment of leukocyte subsets following autologous bone marrow transplantation in acute myeloid leukemia using anti-myeloid (CD14 and CD15) monoclonal antibody-purged bone marrow.
Ericson SG; Colby E; Welch L; Ball ED
Bone Marrow Transplant; 1992 Feb; 9(2):129-37. PubMed ID: 1373982
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow transplantation from HLA-matched unrelated donors as treatment for leukemia.
Champlin R
J Hematother; 1993; 2(3):323-7. PubMed ID: 7921993
[No Abstract] [Full Text] [Related]
18. T cells, graft-versus-host disease and graft-versus-leukemia: innovative approaches for blood and marrow transplantation.
Champlin R; Giralt S; Gajewski J
Acta Haematol; 1996; 95(3-4):157-63. PubMed ID: 8677736
[TBL] [Abstract][Full Text] [Related]
19. Graft-versus-leukemia without graft-versus-host disease: an elusive goal of bone marrow transplantation.
Champlin R
Semin Hematol; 1992 Jul; 29(3 Suppl 2):46-52. PubMed ID: 1509294
[No Abstract] [Full Text] [Related]
20. Bone marrow transplantation in the treatment of acute leukemia.
Klock JC; Vuckovich N
Oncology; 1974; 29(2):147-51. PubMed ID: 4151848
[No Abstract] [Full Text] [Related]
[Next] [New Search]
